HIV infection in vitro enhances the activity of src-family protein tyrosine kinases

AIDS

Volumn 10, Issue 11, 1996, Pages 1191-1198

  Phipps, David J ^a   Read, Stanley E ^b,c   Piovesan, John P ^d   Mills, Gordon B ^a,e   Branch, Donald R ^a,d,f  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Canadian Red Cross Society   (Canada)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Fyn; gp120; HIV; Lck; Protein tyrosine kinase; Signal transduction; src; Src kinases

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; ZIDOVUDINE;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LEUKEMIA CELL LINE; MEMBRANE FUSION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029832569     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199609000-00003     Document Type: Article

References (48)

1. Ascher MS, Sheppard HW: AIDS as immune system activation. II: The panergic imnesia hypothesis. J Acquir Immune Defic Syndr 1990, 3:177-191.
2. Mahalingam M, Peakman M, Davies ET, Pozniak A, McManus TJ, Vergani D: T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993, 93:337-343.
3. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H: Neopterin as a marker for activated cell-mediated immunity. Immunol Today 1988, 9:150-155.
4. Sadat-Sowti B, Debre P: Cytokines and HIV infection. Eur Cytokine Network 1992, 3:515-521.
5. Godfried MH, van der Poll T, Weverling GJ, et al.: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994, 169:739-745.
6. Fahey JL, Taylor JMG, Detels R, et al.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990, 322:166-172.
7. Clouse KA, Cosentino LM, Weih KA, et al.: The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991, 147:2892-2901.
8. Kornfeld H, Cruikshank WW, Pyle SW, et al.: Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 1988, 335:445-448.
9. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G: Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991, 114:678-693.
10. Mann DL, Lesane F, Popovic M, et al.: HTLV III large envelope protein (gp120) suppresses PHA induced lymphocyte blastogenesis. J Immunol 1988, 138:2640-2644.
11. Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greentsein JL, Burakoff SJ: Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J Immunol 1988, 141:3715-3717.
12. lck with CD4 in human T lymphocytes. J Biol Chem 1991, 266:11176-11183.
13. lck in human CD4 lymphocytes. Eur J Immunol 1993, 23:600-607.
14. c-src family of protein tyrosine kinases: structure, regulation and function. Crit Rev Oncogenesis 1992, 3:401-446.
15. c-src expression is induced by activation of normal human T lymphocytes. J Immunol 1995, 154:3678-3685.
16. Phipps DJ, Reed-Doob P, MacFadden DK, Piovesan JP, Mills GB, Branch DR: An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes. Clin Exp Immunol 1995, 100:412-418.
17. Greenway A, Azad A, McPhee D: Human immunodeficiency virus type-1 nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 1995, 69:1842-1850.
18. + viruses but not for down-regulation of CD4. EMBO J 1995, 14:484-491.
19. Mills GB, Arima N, May C: Neither the LCK nor FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-1 infected human T cells. Int Immunol 1992, 4:1233-1243.
20. fyn. J Exp Med 1992, 175:1483-1492.
21. Cooper JA, Hunter T: Identification and characterization of cellular targets for tyrosine protein kinases. J Biol Chem 1983, 258:1108-1115.
22. Scandella CJ, Kilpatrick J, Lidster W, et al.: Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development. AIDS Res Hum Retroviruses 1993, 9:1233-1244.
23. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC: Participation of tyrosine phosphorylation in the cytopathic effect of human immundeficiency virus-1. Science 1992, 256:542-545.
24. lck activation and TCR desensitization independent of TCR. J Immnol 1994, 153:2905-2917.
25. lck. Nature 1989, 338:257-259.
26. Veillette A, Bolen JB, Bookman MA: Alterations in tyrosine protein phosphorylation by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol Cell Biol 1989, 9:4441-4446.
27. Straus DB, Weiss A: Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992, 70:1117-1124.
28. Kim S, Byrn R, Groopman J, Baltimore D: Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol 1989, 63:3708-3713.
29. Laurence J: Resevoirs of HIV infection and carriage: monocyte, dendritic, follicular dendritic and B cells. Ann NY Acad Sci 1993, 693:52-64.
30. Larcher C, Schulz TF, Hofbauer J, et al.: Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T and B cells. J Acquir Immune Defic Syndr 1990, 3:103-108.
31. Harouse JM, Bhat S, Spitalnik SL, et al.: Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991, 253:320-323.
32. Bhat S, Spitalnik SL, Gonzales-Scarano F, Siberberg DH: Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 encelope glycoprotein gp120. Proc Natl Acad Sci USA 1991, 88:7131-7134.
33. Schneider-Schaulies J, Schneider-Schaulies S, Brinkmann R, et al.: HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology 1992, 191:765-772 .
34. Clapham PR, Weber JN, Whitby D, et al.: Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature 1989, 337:368-370.
35. lck complex in human T cell activation. Immunol Rev 1989, 111:225-266.
36. csk. Nature 1993, 365:156-160.
37. lck tyrosine kinase and activates the phosphatase. Mol Cell Biol 1994, 14:1308-1321.
38. Imamoto A, Soriano P: Disruption of the csk gene, encoding a negative regulator of src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 1993, 73:1117-1124
39. csk. Nature 1993, 365:156-160.
40. Lane HC, Depper JM, Green WC, Whaten G, Waldman TA, Fauci AS: Qualitative analysis of immune function in patients with acquired immune deficiency syndrome. N Engl J Med 1985, 313:79-84.
41. Agostini C, Zambello R, Trentin L, et al.: Alveolar macrophages from patients with AIDS and AIDS related complex constitutively synthesize and release tumor necrosis factor. Am Rev Respir Dis 1991, 144:195-201.
42. Vyakarnam A, Matear P, Meager A, et al.: Altered production of tumor necrosis factors alpha and beta and interferon gamma by HIV-1 infected individuals. Clin Exp Immunol 1991, 84:109-115.
43. Weiss A: T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 1993, 73:209-212.
44. Gallay P, Swingler S, Song J, Bushman F, Trono D: HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 1995, 83:569-576.
45. lck in CD4 T cells from HIV-1 infected patients. Int Immunol 1994, 6:611-621.
46. lck, a lymphocyte specific protein tyrosine kinase, on the syncitium formation induced by human immunodeficiency virus envelope glycoprotein. Int Immunol 1992, 4:233-242.
47. lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 1994, 13:774-783.
48. Briant L, Coudronniere N, Robert-Hebmann V, Benkirane M, Devaux C: Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection. J Immunol 1996, 156:3994-4004.